...
首页> 外文期刊>Trials >High-flow nasal cannula versus standard oxygen therapy assisting sedation during endoscopic retrograde cholangiopancreatography in high risk cases (OTHER): study protocol of a randomised multicentric trial
【24h】

High-flow nasal cannula versus standard oxygen therapy assisting sedation during endoscopic retrograde cholangiopancreatography in high risk cases (OTHER): study protocol of a randomised multicentric trial

机译:高流量鼻腔插管与标准氧气疗法在高风险案例(其他)中的内窥镜逆行胆管胰岛素(其他):随机多中心试验的研究方案

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Endoscopic retrograde cholangiopancreatography (ERCP) is an increasingly common intervention in the treatment of pancreaticobiliary disorders. Patients are often elderly with complex co-morbidities. While monitored anaesthesia care with sedation is commonly used for most cases, few would require general anaesthesia with an endotracheal tube. Both low-flow and high-flow nasal cannulas (HFNC) are established ways of delivering supplemental oxygen, but it is unclear whether one technique is better than the other. HFNC seems a promising tool for advanced procedures but evidence to support its application in high-risk ERCP cases is limited. The rate of oxygen desaturation during endoscopy has been reported to be as high as 11%–50% and the method of oxygen delivery for ERCP merits further study. This is a prospective, randomised, multicentre trial comparing the efficacy of oxygen supplementation through HFNC versus low-flow nasal cannula during ERCP, in a cohort of patients at risk of adverse respiratory events. A total of 132 patients will be recruited across three sites and randomly assigned to either the low-flow or the HFNC group. The primary outcome is the proportion of patients experiencing hypoxia, defined by any event of SpO2??90%. The secondary outcomes include parameters centred on oxygenation, requirement of airway manoeuvres, successful completion of procedure, perioperative complications, patient satisfaction and cost analysis of the consumables. An intention-to-treat principle will be applied while analysing. The demand for ERCPs is likely to increase in the future with the aging population. Our study results may lead to improved outcomes and reduce airway-related complications in patients undergoing ERCPs. The results will be presented at national and international meetings and published in peer-reviewed journals. www.ANZCTR.org.au, CTRN12619000397112. Registered on 12 March 2019.
机译:内窥镜逆行胆管胆痴呆(ERCP)是治疗胰腺尿酸血症的越来越常见的干预。患者往往是老年人的复杂性交。在大多数情况下通常使用镇静的监测麻醉护理,而大多数情况下,很少有人需要具有气管插管的全身麻醉。低流量和高流量鼻插管(HFNC)都是建立辅助氧的方式,但目前尚不清楚一种技术是否优于另一种技术。 HFNC似乎是高级程序的有希望的工具,但证据支持其在高风险ERCP案件中的应用是有限的。据报道,内窥镜检查期间的氧气停留率高达11%-50%,ERCP的氧递送方法的优点进一步研究。这是一项预期,随机的多期式试验,比较ERCP期间通过HFNC与低流量鼻腔插管的氧气补充的疗效,以受不良呼吸事件的风险的患者。共有132名患者将在三个地点招募并随机分配给低流量或HFNC组。主要结果是经历缺氧的患者的比例,由SPO2的任何事件定义?<?90%。二次结果包括以氧合,气道机动要求为中心的参数,成功完成程序,围手术期并发症,患者满意度和消耗成本分析。分析时将应用意向治疗原则。随着年龄的人口,对ERCP的需求可能会增加未来。我们的研究结果可能导致改善的结果,并降低接受ERCPS患者的呼吸道相关并发症。结果将在国家和国际会议上展示,并在同行评审期刊上发表。 www.anzctr.org.au,Ctrn12619000397112。 2019年3月12日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号